PE2499A1 - Composiciones con recubrimientos que controlan la liberacion - Google Patents
Composiciones con recubrimientos que controlan la liberacionInfo
- Publication number
- PE2499A1 PE2499A1 PE1997000805A PE00080597A PE2499A1 PE 2499 A1 PE2499 A1 PE 2499A1 PE 1997000805 A PE1997000805 A PE 1997000805A PE 00080597 A PE00080597 A PE 00080597A PE 2499 A1 PE2499 A1 PE 2499A1
- Authority
- PE
- Peru
- Prior art keywords
- active substance
- dihydrogenocitrate
- matrix
- sodium
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619074.9A GB9619074D0 (en) | 1996-09-12 | 1996-09-12 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE2499A1 true PE2499A1 (es) | 1999-03-24 |
Family
ID=10799833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000805A PE2499A1 (es) | 1996-09-12 | 1997-09-10 | Composiciones con recubrimientos que controlan la liberacion |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0929301A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001500150A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20000036039A (cg-RX-API-DMAC7.html) |
| CN (2) | CN1235544A (cg-RX-API-DMAC7.html) |
| AR (1) | AR008176A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU724086B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9711734A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2265661A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO5031291A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ83299A3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB9619074D0 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP9904401A3 (cg-RX-API-DMAC7.html) |
| ID (1) | ID19589A (cg-RX-API-DMAC7.html) |
| IL (1) | IL128781A0 (cg-RX-API-DMAC7.html) |
| MA (1) | MA24359A1 (cg-RX-API-DMAC7.html) |
| NO (1) | NO991194L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ334268A (cg-RX-API-DMAC7.html) |
| PE (1) | PE2499A1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL332074A1 (cg-RX-API-DMAC7.html) |
| TR (1) | TR199900505T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998010762A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA978133B (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2775597B1 (fr) * | 1998-03-04 | 2001-04-20 | Gattefosse Ets Sa | Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication |
| PL342600A1 (en) | 1998-03-11 | 2001-06-18 | Smithkline Beecham Plc | Composition |
| DE19918325A1 (de) * | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
| FR2796840B1 (fr) | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
| US6733781B2 (en) * | 2000-12-06 | 2004-05-11 | Wyeth | Fast dissolving tablet |
| PA8578501A1 (es) | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| KR101139744B1 (ko) | 2003-04-25 | 2012-04-26 | 미쓰비시 타나베 파마 코퍼레이션 | 알킬렌 디옥시벤젠 유도체 함유 경구 투여용 조성물 |
| ES2273271T5 (es) * | 2003-05-14 | 2013-05-21 | Aptalis Pharma Limited | Composición de liberación controlada de fármaco resistente a la tensión mecánica in vivo |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| JP2005272347A (ja) * | 2004-03-24 | 2005-10-06 | Ohara Yakuhin Kogyo Kk | 固形製剤の製造方法 |
| EP1778201B1 (en) * | 2004-08-13 | 2014-07-16 | Boehringer Ingelheim International GmbH | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| ATE486588T1 (de) | 2004-08-13 | 2010-11-15 | Boehringer Ingelheim Int | Tablettenformulierung mit verlängerter freisetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon, herstellungsverfahren und verwendung dafür |
| EP1970056A1 (en) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Time-specific delayed/pulsatile release dosage forms |
| US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
| JP2022529189A (ja) * | 2019-04-19 | 2022-06-17 | ホフマン・テクノロジーズ・エルエルシー | 持続放出製剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2219636T3 (es) * | 1989-04-13 | 2004-12-01 | Beecham Group P.L.C. | Nuevos compuestos. |
| GB9409718D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| GB9421472D0 (en) * | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
| AR004178A1 (es) * | 1995-07-29 | 1998-11-04 | Smithkline Beecham Plc | Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. |
-
1996
- 1996-09-12 GB GBGB9619074.9A patent/GB9619074D0/en active Pending
-
1997
- 1997-09-08 WO PCT/GB1997/002418 patent/WO1998010762A2/en not_active Ceased
- 1997-09-08 KR KR1019997002030A patent/KR20000036039A/ko not_active Ceased
- 1997-09-08 HU HU9904401A patent/HUP9904401A3/hu unknown
- 1997-09-08 BR BR9711734A patent/BR9711734A/pt unknown
- 1997-09-08 AU AU41288/97A patent/AU724086B2/en not_active Ceased
- 1997-09-08 PL PL97332074A patent/PL332074A1/xx unknown
- 1997-09-08 EP EP97939064A patent/EP0929301A2/en not_active Withdrawn
- 1997-09-08 IL IL12878197A patent/IL128781A0/xx unknown
- 1997-09-08 CN CN97199411A patent/CN1235544A/zh active Pending
- 1997-09-08 TR TR1999/00505T patent/TR199900505T2/xx unknown
- 1997-09-08 NZ NZ334268A patent/NZ334268A/xx unknown
- 1997-09-08 CZ CZ99832A patent/CZ83299A3/cs unknown
- 1997-09-08 CA CA002265661A patent/CA2265661A1/en not_active Abandoned
- 1997-09-08 JP JP10513352A patent/JP2001500150A/ja active Pending
- 1997-09-09 CO CO97052280A patent/CO5031291A1/es unknown
- 1997-09-10 AR ARP970104130A patent/AR008176A1/es not_active Application Discontinuation
- 1997-09-10 MA MA24792A patent/MA24359A1/fr unknown
- 1997-09-10 PE PE1997000805A patent/PE2499A1/es not_active Application Discontinuation
- 1997-09-10 ID IDP973137A patent/ID19589A/id unknown
- 1997-09-10 ZA ZA978133A patent/ZA978133B/xx unknown
-
1999
- 1999-03-11 NO NO991194A patent/NO991194L/no unknown
-
2003
- 2003-01-23 CN CN03102977A patent/CN1446535A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TR199900505T2 (cg-RX-API-DMAC7.html) | 1999-06-21 |
| CN1446535A (zh) | 2003-10-08 |
| NZ334268A (en) | 2000-10-27 |
| GB9619074D0 (en) | 1996-10-23 |
| CN1235544A (zh) | 1999-11-17 |
| WO1998010762A2 (en) | 1998-03-19 |
| AU724086B2 (en) | 2000-09-14 |
| CO5031291A1 (es) | 2001-04-27 |
| EP0929301A2 (en) | 1999-07-21 |
| PL332074A1 (en) | 1999-08-30 |
| CA2265661A1 (en) | 1998-03-19 |
| MA24359A1 (fr) | 1998-07-01 |
| CZ83299A3 (cs) | 1999-08-11 |
| KR20000036039A (ko) | 2000-06-26 |
| HUP9904401A3 (en) | 2001-03-28 |
| ZA978133B (en) | 1999-04-12 |
| HUP9904401A2 (hu) | 2000-06-28 |
| IL128781A0 (en) | 2000-01-31 |
| AU4128897A (en) | 1998-04-02 |
| BR9711734A (pt) | 1999-08-24 |
| AR008176A1 (es) | 1999-12-09 |
| NO991194D0 (no) | 1999-03-11 |
| WO1998010762A3 (en) | 1998-06-04 |
| NO991194L (no) | 1999-03-11 |
| ID19589A (id) | 1998-07-23 |
| JP2001500150A (ja) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE2499A1 (es) | Composiciones con recubrimientos que controlan la liberacion | |
| US6106862A (en) | Once daily analgesic tablet | |
| US6531152B1 (en) | Immediate release gastrointestinal drug delivery system | |
| US5750145A (en) | Stable gelatin coated aspirin tablets | |
| EP1021171B1 (en) | Delayed total release gastrointestinal drug delivery system | |
| US7485322B2 (en) | Modified release pharmaceutical composition | |
| FI88675B (fi) | Elastiska filmoeverdrag och deras anvaendning | |
| AU674583B2 (en) | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions | |
| CA2170748A1 (en) | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis | |
| EP0248447A2 (en) | Sustained release formulations | |
| ES2245071T3 (es) | Procedimiento para obtener una preparacion de tramadol retardada con un perfil de liberacion estable en almacenamiento sin necesidad de tratar termicamente el producto revestido. | |
| IL118240A (en) | Oral coated capsule dosage form of omega-3 polyunsaturated acid for release of the acid in the intestine | |
| UA72483C2 (en) | Moxifloxacin-containing pharmaceutical preparation and method for its manufacture | |
| HUP9900800A2 (hu) | Szerves vegyületeket tartalmazó készítmények | |
| TW200602085A (en) | Controlled-release pharmaceutical composition and method for producing same | |
| BR0109934A (pt) | Preparação e prevenção de diarréia de ácido biliar | |
| CA2229283A1 (en) | Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease | |
| BR0212155A (pt) | Composição farmacêutica | |
| ES2184452T3 (es) | Preparacion farmaceutica que contiene levotiroxina de sodio. | |
| IE58621B1 (en) | Pancreatic enzyme products and a process for the preparation thereof | |
| US5958873A (en) | Oral formulation for treatment of bacteria-induced diseases of the colon | |
| CA2055905A1 (en) | Pharmaceutical composition comprising calcium polycarbophil | |
| ES2234301T3 (es) | Acetaminofeno de liberacion prolongada. | |
| FR2845289B1 (fr) | Spheroides, procede de preparation et compositions pharmaceutiques. | |
| BR9912533A (pt) | Composição farmacêutica tendo sabor melhorado |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |